Atlas Trials

Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.

Clinical trial NCT02907827 · UNKNOWN

Trial details

NCT number
NCT02907827
Sponsor
Universitair Ziekenhuis Brussel
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Melanoma
Start date
2014-11-01
Primary completion
2025-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.